review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/CMI.12371 |
P698 | PubMed publication ID | 25266336 |
P50 | author | Jaclyn S Pearson | Q58204671 |
Elizabeth L. Hartland | Q47502191 | ||
P2093 | author name string | Ralf Schuelein | |
Tania Wong Fok Lung | |||
P2860 | cites work | Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function | Q24293521 |
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation | Q24301668 | ||
The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations | Q24302236 | ||
A bacterial effector targets host DH-PH domain RhoGEFs and antagonizes macrophage phagocytosis | Q24304013 | ||
The role of receptor internalization in CD95 signaling | Q24305510 | ||
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes | Q24312187 | ||
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism | Q27685465 | ||
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation | Q27732032 | ||
Metalloprotease type III effectors that specifically cleave JNK and NF-κB | Q28116010 | ||
FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts | Q28138932 | ||
Death and anti-death: tumour resistance to apoptosis | Q28217065 | ||
JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation | Q28243308 | ||
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis | Q28257134 | ||
Death receptors: signaling and modulation | Q28280897 | ||
Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function | Q28359876 | ||
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 | ||
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling | Q29568915 | ||
AP-1 in cell proliferation and survival | Q29615217 | ||
Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO | Q29618712 | ||
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
Suppression of TNF-alpha-induced apoptosis by NF-kappaB | Q29618717 | ||
AP-1: a double-edged sword in tumorigenesis | Q30014831 | ||
The E. coli effector protein NleF is a caspase inhibitor | Q30456165 | ||
Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation | Q33187061 | ||
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. | Q33582255 | ||
CD98hc (SLC3A2) mediates integrin signaling. | Q33722588 | ||
NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection | Q33733678 | ||
NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA | Q33780981 | ||
Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements | Q34177961 | ||
The many roles of FAS receptor signaling in the immune system | Q34205697 | ||
XIAP discriminates between type I and type II FAS-induced apoptosis | Q34205704 | ||
The interplay between the Escherichia coli Rho guanine nucleotide exchange factor effectors and the mammalian RhoGEF inhibitor EspH | Q34247723 | ||
Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway | Q34356501 | ||
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis | Q34387272 | ||
Citrobacter rodentium of mice and man. | Q34470352 | ||
Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins | Q34478656 | ||
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium | Q34492843 | ||
Glutamine Deamidation and Dysfunction of Ubiquitin/NEDD8 Induced by a Bacterial Effector Family | Q34540701 | ||
EspO1-2 regulates EspM2-mediated RhoA activity to stabilize formation of focal adhesions in enterohemorrhagic Escherichia coli-infected host cells | Q34586498 | ||
Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition | Q48217964 | ||
RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis. | Q49048892 | ||
Two tumour necrosis factor receptors: structure and function. | Q49167492 | ||
Enteropathogenic Escherichia coli outer membrane proteins induce changes in cadherin junctions of Caco-2 cells through activation of PKCalpha. | Q50767772 | ||
Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. | Q52560716 | ||
Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. | Q52574553 | ||
Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. | Q53594276 | ||
Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. | Q53898008 | ||
Escherichia coli cyclomodulin Cif induces G2 arrest of the host cell cycle without activation of the DNA-damage checkpoint-signalling pathway. | Q54459476 | ||
Nutritional impact and ultrastructural intestinal alterations in severe infections due to enteropathogenic Escherichia coli strains in infants. | Q54590996 | ||
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation | Q57372470 | ||
A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens | Q34642972 | ||
Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis | Q34659851 | ||
Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium | Q35011197 | ||
A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation | Q35228516 | ||
Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation. | Q35886703 | ||
NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation | Q36557738 | ||
Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death | Q36586837 | ||
An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins | Q36935282 | ||
Dissecting virulence: systematic and functional analyses of a pathogenicity island | Q37074383 | ||
A type III effector antagonizes death receptor signalling during bacterial gut infection | Q37331618 | ||
Salmonella typhimurium invasion induces apoptosis in infected macrophages | Q37364881 | ||
The two different receptors for tumor necrosis factor mediate distinct cellular responses | Q37609601 | ||
The EspF effector, a bacterial pathogen's Swiss army knife | Q37777278 | ||
Bax inhibitor 1 in apoptosis and disease. | Q37836378 | ||
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. | Q38172752 | ||
Inhibition of death receptor signaling by bacterial gut pathogens. | Q38179702 | ||
Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome | Q38985852 | ||
Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance. | Q39514491 | ||
Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili | Q39522797 | ||
The bacterial effector Cif interferes with SCF ubiquitin ligase function by inhibiting deneddylation of Cullin1 | Q39654433 | ||
Outer membrane proteins of wild-type and intimin-deficient enteropathogenic Escherichia coli induce Hep-2 cell death through intrinsic and extrinsic pathways of apoptosis | Q39943221 | ||
Bacterial cyclomodulin Cif blocks the host cell cycle by stabilizing the cyclin-dependent kinase inhibitors p21 and p27. | Q39950337 | ||
Caspases-3, -8, and -9 are required for induction of epithelial cell apoptosis by enteropathogenic E. coli but are dispensable for increased paracellular permeability | Q40041562 | ||
Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels. | Q40183668 | ||
Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). | Q40270542 | ||
Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens | Q40380291 | ||
Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. | Q40391965 | ||
The type III secretion effector NleE inhibits NF-kappaB activation | Q41893338 | ||
The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation | Q42067854 | ||
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis | Q42093656 | ||
EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation | Q42103443 | ||
Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation | Q42152368 | ||
Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains | Q42152411 | ||
Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli | Q42177912 | ||
Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium | Q42808304 | ||
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles | Q42825650 | ||
Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways | Q43613076 | ||
Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. | Q45986472 | ||
Structural requirements for signal-induced target binding of FADD determined by functional reconstitution of FADD deficiency | Q46595056 | ||
P433 | issue | 12 | |
P921 | main subject | cell death | Q2383867 |
Enteropathogenic Escherichia coli | Q13419512 | ||
Escherichia coli | Q25419 | ||
enteropathogen | Q63500873 | ||
P304 | page(s) | 1736-1745 | |
P577 | publication date | 2014-10-30 | |
P1433 | published in | Cellular Microbiology | Q1921948 |
P1476 | title | The cell death response to enteropathogenic Escherichia coli infection | |
P478 | volume | 16 |
Q47097262 | Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors |
Q26751034 | Bacterial Control of Pores Induced by the Type III Secretion System: Mind the Gap |
Q38718756 | Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli |
Q98891949 | Emerging connectivity of programmed cell death pathways and its physiological implications |
Q42592138 | Engineering the Controlled Assembly of Filamentous Injectisomes in E. coli K-12 for Protein Translocation into Mammalian Cells |
Q38762934 | EspC, an Autotransporter Protein Secreted by Enteropathogenic Escherichia coli, Causes Apoptosis and Necrosis through Caspase and Calpain Activation, Including Direct Procaspase-3 Cleavage |
Q90682646 | Intestinal cell migration damage induced by enteropathogenic Escherichia coli strains |
Search more.